Washington Examiner
US · 13 mins ago
✦ 78→ Right
GLP-1 market shows how Americans can get lower drug prices
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 35/100
ObjectivePartisan
→ Right ✓ Fair headline
The article reports that GLP-1 weight-loss drugs are becoming cheaper in the U.S. market, with examples of significant price drops for medications like Wegovy and Zepbound, and notes that over 1 in 10 American adults currently use these drugs.
GLP-1 market shows how Americans can get lower drug prices
More than 1 in 10 U.S. adults is currently taking a GLP-1 weight-loss drug. And these medicines are getting cheaper seemingly by the day. Since Wegovy launched, its list price has fallen from roughly $1,300 per month to between $300 and $500 per month. Similarly, Zepbound was once about $1,000 per month, but it now […]
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!